Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00713596 · ClinicalTrials.gov registry record · NA

Study Evaluating Benefit of Using Fibrin Glue in Septorhinoplasty

A NA study, sponsored by Mayo Clinic.

Terminated
Registry status
NA
Development phase
25
Enrollment target

NCT00713596: Clinical Trial NA study, sponsored by Mayo Clinic.

NCT00713596 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00713596, a NA study, was terminated before completion, sponsored by Mayo Clinic.

TERMINATED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether the use of fibrin glue during nasal surgery leads to a shorter recovery period with less bruising and/or swelling.

Primary Outcome

ROE: 6 items for subject's opinion re: nasal appearance, each item on 0-4 scale. Total score sum of 6 items, dividing total by 24 X 100, core ranges from 0 (least satisfied) to 100 (most satisfied). NOSE: Assess five conditions over the past month, each item on 0-4 scale X 5, then summed. Total score ranges from 0 (no problem) to 100 (severe problem). Global measure of nose deformity: Pictures of 4 indices of nasal anatomy: length, width, tip, and hump. Each index cored from 1-7, with 1=ideal

Interventions

  • OTHER Saline
  • DRUG Fibrinogen
  • PROCEDURE Septorhinoplasty
  • PROCEDURE Taping after septorhinoplasty.
  • PROCEDURE Cast applied to the nose after nasal surgery

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2008-07
Est. Completion 2010-01
Phase NA
Mayo Clinic

2,844 total trials

Why NCT00713596 stopped before completion

NCT00713596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 5 interventions - of which Saline is the first listed.

NCT00713596 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00713596 about?

NCT00713596 is a clinical study titled "Study Evaluating Benefit of Using Fibrin Glue in Septorhinoplasty". The purpose of this study is to determine whether the use of fibrin glue during nasal surgery leads to a shorter recovery period with less bruising and/or swelling.

What is the current status of trial NCT00713596?

This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2008-07. Estimated completion is 2010-01.

What interventions are being tested in trial NCT00713596?

The interventions under investigation include: Saline (OTHER), Fibrinogen (DRUG), Septorhinoplasty (PROCEDURE), Taping after septorhinoplasty. (PROCEDURE), Cast applied to the nose after nasal surgery (PROCEDURE).

Who is sponsoring clinical trial NCT00713596?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00713596's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00713596, the US trial registry maintained by the National Library of Medicine. NCT00713596 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.